CircITGB6 promotes ovarian cancer cisplatin resistance by resetting tumor-associated macrophage polarization toward the M2 phenotype.
Li H, Luo F, Jiang X, Zhang W, Xiang T, Pan Q, Cai L, Zhao J, Weng D, Li Y, Dai Y, Sun F, Yang C, Huang Y, Yang J, Tang Y, Han Y, He M, Zhang Y, Song L, Xia JC.
Li H, et al. Among authors: pan q.
J Immunother Cancer. 2022 Mar;10(3):e004029. doi: 10.1136/jitc-2021-004029.
J Immunother Cancer. 2022.
PMID: 35277458
Free PMC article.